News Conference News TCT 2025 DOAC May Be Safer Than DAPT After Left Atrial Appendage Closure: ANDES Yael L. Maxwell November 04, 2025
News Conference News TCT 2024 LAAO Outcomes Similar Regardless of Operator’s Specialty Todd Neale October 27, 2024
News Conference News TCT 2023 WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone Todd Neale October 24, 2023
News Conference News TCT 2022 Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes Todd Neale September 18, 2022
News Conference News TCT 2021 Amulet LAA Closure Device Has Fewer Leaks Than Watchman: Does It Matter? Todd Neale November 06, 2021
News Conference News TCT 2021 PRAGUE-17: LAA Occlusion Noninferior to DOACs Over Longer Term Todd Neale November 05, 2021
News Conference News TCT 2021 LAA Closure Feasible in Patients With Thrombus: Registry Michael O'Riordan October 13, 2021
News Conference News TCT 2019 Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA Todd Neale October 04, 2019
News Conference News TCT 2018 Novel LAA Closure Device Shows Promise in Early Experience L.A. McKeown September 22, 2018
News Conference News TCT 2017 Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used Todd Neale November 02, 2017
News Conference News TCT 2015 LAA Closure Trials Illustrate Evolution of Devices, Trial Design October 12, 2015
News Conference News TCT 2015 Use of LAA Occlusion in Low-Risk Patients Debated Todd Neale October 11, 2015
Presentation TCT 2014 Cost-effectiveness Analysis Of Left Atrial Appendage Occlusion Device Compared With 7 Oral Anticoagulants For Stroke Prevention In Atrial Fibrillation Presenter: Vivian Lee September 16, 2014
Presentation TCT 2014 Comparison of Imputed Placebo Versus Observed Ischemic Stroke Rates in the Watchman Trials Represents a Significant Reduction in Risk Presenter: George Hanzel September 16, 2014
Presentation TCT 2014 TCT 170: Cost-effectiveness Analysis of a Left Atrial Appendage Occlusion Device Compared with 7 Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation Presenter: Saibal Kar, Bushra S Rana, Jai-Wun Park, Vivian Lee September 15, 2014
Presentation TCT 2014 Old and New Anticoagulants for Stroke Prevention: Benefits and Risks Presenter: Josep Rodés-Cabau, Brian K. Whisenant, David Hildick-Smith, Jonathan L. Halperin September 15, 2014
Presentation TCT 2014 Stroke, Bleeding, and Risk Scores in Atrial Fibrillation Presenter: Josep Rodés-Cabau, Brian K. Whisenant, David Hildick-Smith, Stefan C. Bertog September 15, 2014
Presentation TCT 2014 Can LAA Closure Become the New Standard for Stroke Prevention? Presenter: Hilary Nierenberg, Julie Logan, Saibal Kar September 14, 2014
News Conference News TCT 2014 LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF September 14, 2014
News Conference News TCT 2013 Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients October 30, 2013